Udy AA - Search Results

1

The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study.

Hodgson CL, Higgins AM, Bailey MJ, Mather AM, Beach L, Bellomo R, Bissett B, Boden IJ, Bradley S, Burrell A, Cooper DJ, Fulcher BJ, Haines KJ, Hopkins J, Jones AYM, Lane S, Lawrence D, van der Lee L, Liacos J, Linke NJ, Gomes LM, Nickels M, Ntoumenopoulos G, Myles PS, Patman S, Paton M, Pound G, Rai S, Rix A, Rollinson TC, Sivasuthan J, Tipping CJ, Thomas P, Trapani T, Udy AA, Whitehead C, Hodgson IT, Anderson S, Neto AS; COVID-Recovery Study Investigators and the ANZICS Clinical Trials Group. Hodgson CL, et al. Among authors: udy aa. Crit Care. 2021 Nov 8;25(1):382. doi: 10.1186/s13054-021-03794-0. Crit Care. 2021. PMID: 34749756 Free PMC article.

2

Do burn patients cost more? The intensive care unit costs of burn patients compared with controls matched for length of stay and acuity.

Patil V, Dulhunty JM, Udy A, Thomas P, Kucharski G, Lipman J. Patil V, et al. J Burn Care Res. 2010 Jul-Aug;31(4):598-602. doi: 10.1097/BCR.0b013e3181e4d6a4. J Burn Care Res. 2010. PMID: 20489652

3

A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Udy AA, Paul SK, Lipman J; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian Society for Infectious Diseases Clinical Research Network. Dulhunty JM, et al. Among authors: udy aa. Crit Care Resusc. 2013 Sep;15(3):179-85. Crit Care Resusc. 2013. PMID: 23944203 Clinical Trial.

4

Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*.

Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, Boots RJ, Lipman J. Udy AA, et al. Crit Care Med. 2014 Mar;42(3):520-7. doi: 10.1097/CCM.0000000000000029. Crit Care Med. 2014. PMID: 24201175

5

Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.

Udy AA, Jarrett P, Stuart J, Lassig-Smith M, Starr T, Dunlop R, Wallis SC, Roberts JA, Lipman J. Udy AA, et al. Crit Care. 2014 Nov 29;18(6):657. doi: 10.1186/s13054-014-0657-z. Crit Care. 2014. PMID: 25432141 Free PMC article.

6

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Udy AA, Lipman J, Jarrett P, Klein K, Wallis SC, Patel K, Kirkpatrick CM, Kruger PS, Paterson DL, Roberts MS, Roberts JA. Udy AA, et al. Crit Care. 2015 Jan 30;19(1):28. doi: 10.1186/s13054-015-0750-y. Crit Care. 2015. PMID: 25632974 Free PMC article.

7

The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.

Shekar K, Fraser JF, Taccone FS, Welch S, Wallis SC, Mullany DV, Lipman J, Roberts JA; ASAP ECMO Study Investigators. Shekar K, et al. Crit Care. 2014 Dec 12;18(6):565. doi: 10.1186/s13054-014-0565-2. Crit Care. 2014. PMID: 25636084 Free PMC article.

8

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J; BLING II Investigators for the ANZICS Clinical Trials Group *. Dulhunty JM, et al. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1298-305. doi: 10.1164/rccm.201505-0857OC. Am J Respir Crit Care Med. 2015. PMID: 26200166 Clinical Trial.

9

The Association Between Low Admission Peak Plasma Creatinine Concentration and In-Hospital Mortality in Patients Admitted to Intensive Care in Australia and New Zealand.

Udy AA, Scheinkestel C, Pilcher D, Bailey M; Australian and New Zealand Intensive Care Society Centre for Outcomes and Resource Evaluation. Udy AA, et al. Crit Care Med. 2016 Jan;44(1):73-82. doi: 10.1097/CCM.0000000000001348. Crit Care Med. 2016. PMID: 26474114

10

Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill.

Mitrić G, Udy A, Bandeshe H, Clement P, Boots R. Mitrić G, et al. Crit Care. 2016 Apr 2;20:90. doi: 10.1186/s13054-016-1252-2. Crit Care. 2016. PMID: 27038791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page